3rd Mar 2008 15:00
Skyepharma PLC03 March 2008 For Immediate Release 3 March 2008 SkyePharma PLC ("the Company") The Company was informed on 29 February 2008 that as a result of transactions on29 February 2008 by the SkyePharma PLC Share Purchase Plan (an approved allemployee share purchase plan) the Trustees of the Plan purchased an additional11,298 Ordinary Shares of the Company at a price of 12.75 pence per share. Following these transactions, the Trustees hold on behalf of the Plan, 182,309Ordinary Shares representing 0.022% of the share capital of the Company. Theclass of discretionary beneficiaries for whom the Trustees hold such sharesconsists of employees of the Company, including the following ExecutiveDirectors: Frank Condella and Peter Grant. As a result of these transactions, the following Executive Directors have thefollowing additional interests as a result of their personal participation inthe Plan:- Partnership Shares Matching Shares awarded Total number of purchased on 29 on 29 February 2008 at Partnership and Matching February 2008 at 12.75p 12.75p per share Shares held on 29 per share February 2008 Frank Condella 981 981 26,970Peter Grant 981 981 19,598 In accordance with the rules of the Plan these Directors have been awardedMatching Shares on the basis of one Matching Share (Ordinary Share) for eachPartnership Share (Ordinary Share). The beneficial ownership of the Matching Shares will pass to the Directors inthree years' time subject to continued employment and the retention of theunderlying Partnership Shares. The execution of the transaction noted above did not involve any of theCompany's Directors or any persons discharging managerial responsibility. This notification relates to transactions notified in accordance with Disclosureand Transparency Rule 3.1.4R(1)(a). This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L